See more : Hecla Mining Company (HL-PB) Income Statement Analysis – Financial Results
Complete financial analysis of Community Health Systems, Inc. (CYH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Community Health Systems, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Enbridge Inc. (EBPPF) Income Statement Analysis – Financial Results
- adidas AG (ADS.F) Income Statement Analysis – Financial Results
- Cann Global Limited (CGB.AX) Income Statement Analysis – Financial Results
- Sing Holdings Limited (5IC.SI) Income Statement Analysis – Financial Results
- Metall Zug AG (METN.SW) Income Statement Analysis – Financial Results
Community Health Systems, Inc. (CYH)
About Community Health Systems, Inc.
Community Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. The company also provides outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, retail clinics, and direct-to-consumer virtual health visits. As of December 31, 2021, it owned or leased 83 hospitals, including 81 general acute care hospitals and two stand-alone rehabilitation or psychiatric hospitals with an aggregate of 13,289 licensed beds. The company was founded in 1985 and is headquartered in Franklin, Tennessee.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.49B | 12.21B | 12.37B | 11.79B | 13.21B | 14.16B | 15.35B | 18.44B | 19.44B | 18.64B | 13.00B | 13.03B | 11.91B | 11.40B | 12.11B | 10.84B | 7.13B | 4.37B | 3.74B | 3.33B | 2.83B | 2.20B | 1.69B | 1.34B | 1.08B |
| Cost of Revenue | 7.41B | 7.31B | 7.28B | 7.37B | 8.10B | 8.74B | 10.05B | 11.64B | 12.04B | 11.48B | 8.21B | 8.08B | 1.83B | 1.77B | 6.53B | 5.85B | 3.84B | 2.25B | 1.93B | 1.74B | 912.80M | 1.38B | 323.81M | 259.47M | 209.08M |
| Gross Profit | 5.08B | 4.91B | 5.08B | 4.42B | 5.11B | 5.42B | 5.31B | 6.80B | 7.40B | 7.16B | 4.79B | 4.95B | 10.07B | 9.63B | 5.58B | 4.99B | 3.29B | 2.11B | 1.80B | 1.59B | 1.92B | 817.99M | 1.37B | 1.08B | 870.87M |
| Gross Profit Ratio | 40.69% | 40.18% | 41.11% | 37.45% | 38.70% | 38.26% | 34.55% | 36.90% | 38.06% | 38.41% | 36.82% | 38.00% | 84.60% | 84.46% | 46.08% | 46.08% | 46.13% | 48.42% | 48.25% | 47.80% | 67.80% | 37.17% | 80.88% | 80.60% | 80.64% |
| Research & Development | 80.00M | 85.00M | 108.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 319.00M | 317.00M | 308.00M | 327.00M | 321.00M | 337.00M | 394.00M | 450.00M | 457.00M | 434.00M | 287.41M | 272.83M | 5.83B | 5.50B | 247.13M | 4.56B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 319.00M | 317.00M | 308.00M | 327.00M | 321.00M | 337.00M | 394.00M | 450.00M | 457.00M | 434.00M | 287.41M | 272.83M | 5.83B | 5.50B | 247.13M | 4.56B | 2.49B | 1.54B | 1.23B | 1.10B | 1.49B | 1.84B | 1.06B | 825.29M | 683.96M |
| Other Expenses | 3.73B | 3.70B | 3.35B | 2.91B | 3.91B | 4.19B | 4.70B | 5.28B | 5.53B | 5.24B | 3.50B | 3.47B | 4.89B | 4.60B | 4.26B | 1.71B | 316.22M | 191.57M | 167.67M | 158.26M | 145.75M | 120.45M | 119.67M | 97.62M | 81.65M |
| Operating Expenses | 4.13B | 4.01B | 3.66B | 3.24B | 4.23B | 4.53B | 5.09B | 5.73B | 5.99B | 5.68B | 3.78B | 3.74B | 9.00B | 8.51B | 4.51B | 9.86B | 2.80B | 1.73B | 1.40B | 1.25B | 1.63B | 1.96B | 1.18B | 922.92M | 765.61M |
| Cost & Expenses | 11.53B | 11.32B | 10.94B | 10.62B | 12.33B | 13.27B | 15.14B | 17.36B | 18.03B | 17.16B | 12.00B | 11.82B | 10.84B | 10.28B | 11.04B | 9.86B | 6.64B | 3.99B | 3.33B | 2.99B | 2.54B | 1.96B | 1.50B | 1.18B | 974.70M |
| Interest Income | 2.00M | 2.00M | 3.00M | 3.00M | 3.00M | 7.00M | 11.00M | 0.00 | 0.00 | 0.00 | 2.98M | 0.00 | 4.65M | 1.76M | 3.56M | 7.06M | 8.18M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 832.00M | 858.00M | 885.00M | 1.03B | 1.04B | 976.00M | 931.00M | 962.00M | 973.00M | 972.00M | 615.15M | 622.93M | 649.06M | 653.68M | 648.96M | 658.98M | 364.53M | 102.30M | 94.61M | 77.86M | 71.09M | 62.86M | 94.55M | 0.00 | 0.00 |
| Depreciation & Amortization | 505.00M | 534.00M | 540.00M | 558.00M | 608.00M | 700.00M | 861.00M | 1.10B | 1.17B | 1.19B | 782.68M | 725.56M | 657.67M | 609.84M | 566.54M | 506.69M | 332.58M | 188.77M | 166.16M | 158.38M | 143.77M | 118.22M | 119.67M | 97.62M | 81.65M |
| EBITDA | 1.54B | 1.74B | 1.93B | 2.02B | 1.23B | 970.00M | -1.00B | 307.00M | 2.57B | 2.42B | 1.63B | 1.86B | 1.78B | 1.77B | 1.66B | 1.53B | 824.19M | 569.23M | 571.70M | 500.85M | 434.54M | 359.73M | 308.71M | 252.74M | 186.91M |
| EBITDA Ratio | 12.36% | 11.79% | 16.07% | 14.78% | 11.39% | 11.37% | 7.11% | 12.03% | 13.61% | 14.57% | 14.05% | 15.18% | 14.54% | 15.13% | 13.72% | 13.75% | 11.86% | 13.04% | 15.29% | 14.94% | 15.33% | 16.35% | 18.23% | 18.90% | 17.31% |
| Operating Income | 957.00M | 821.00M | 1.40B | 1.13B | 896.00M | 208.00M | -1.88B | -860.00M | 1.34B | 1.38B | 899.76M | 1.21B | 1.13B | 1.11B | 1.07B | 983.57M | 485.69M | 380.46M | 405.53M | 338.87M | 290.77M | 241.51M | 189.04M | 155.11M | 105.26M |
| Operating Income Ratio | 7.66% | 6.72% | 11.34% | 9.55% | 6.78% | 1.47% | -12.23% | -4.66% | 6.88% | 7.40% | 6.92% | 9.29% | 9.53% | 9.78% | 8.83% | 9.07% | 6.81% | 8.72% | 10.85% | 10.17% | 10.26% | 10.98% | 11.16% | 11.60% | 9.75% |
| Total Other Income/Expenses | -750.00M | -472.00M | -903.00M | -704.00M | -1.08B | -923.00M | -955.00M | -855.00M | -926.00M | -997.00M | -611.14M | -706.35M | -660.94M | -606.49M | -622.54M | -607.34M | -378.39M | -104.10M | -94.61M | -72.44M | -71.09M | -62.86M | -94.55M | -127.37M | -116.49M |
| Income Before Tax | 207.00M | 349.00M | 499.00M | 422.00M | -430.00M | -715.00M | -2.83B | -1.72B | 411.00M | 342.00M | 305.86M | 503.77M | 473.55M | 508.43M | 446.13M | 336.14M | 102.90M | 278.16M | 310.92M | 260.22M | 219.68M | 178.65M | 94.50M | 27.74M | -11.24M |
| Income Before Tax Ratio | 1.66% | 2.86% | 4.03% | 3.58% | -3.26% | -5.05% | -18.45% | -9.30% | 2.11% | 1.83% | 2.35% | 3.87% | 3.98% | 4.46% | 3.68% | 3.10% | 1.44% | 6.37% | 8.32% | 7.81% | 7.75% | 8.12% | 5.58% | 2.07% | -1.04% |
| Income Tax Expense | 191.00M | 170.00M | 131.00M | -185.00M | 160.00M | -11.00M | -449.00M | -104.00M | 116.00M | 82.00M | 88.59M | 157.50M | 137.65M | 159.99M | 141.33M | 129.48M | 43.00M | 106.68M | 120.78M | 102.00M | 88.21M | 73.39M | 45.94M | 18.17M | 5.55M |
| Net Income | -133.00M | 179.00M | 368.00M | 511.00M | -590.00M | -788.00M | -2.46B | -1.72B | 158.00M | 92.00M | 141.20M | 265.64M | 201.95M | 279.98M | 243.15M | 218.30M | 30.29M | 168.26M | 167.54M | 151.43M | 131.47M | 99.98M | 44.74M | 9.57M | -16.79M |
| Net Income Ratio | -1.06% | 1.47% | 2.98% | 4.33% | -4.47% | -5.57% | -16.02% | -9.33% | 0.81% | 0.49% | 1.09% | 2.04% | 1.70% | 2.46% | 2.01% | 2.01% | 0.42% | 3.85% | 4.48% | 4.54% | 4.64% | 4.54% | 2.64% | 0.72% | -1.55% |
| EPS | -1.02 | 1.39 | 2.90 | 4.42 | -5.19 | -6.99 | -22.00 | -15.55 | 1.38 | 0.82 | 1.51 | 2.98 | 2.24 | 3.05 | 2.68 | 2.34 | 0.32 | 1.77 | 1.89 | 1.58 | 1.34 | 1.02 | 0.51 | 0.14 | -0.31 |
| EPS Diluted | -1.02 | 1.38 | 2.82 | 4.38 | -5.19 | -6.99 | -22.00 | -15.54 | 1.37 | 0.82 | 1.51 | 2.96 | 2.23 | 3.01 | 2.66 | 2.32 | 0.32 | 1.75 | 1.79 | 1.51 | 1.30 | 1.00 | 0.50 | 0.14 | -0.31 |
| Weighted Avg Shares Out | 130.39M | 128.81M | 126.75M | 115.49M | 113.74M | 112.73M | 111.77M | 110.71M | 114.00M | 112.00M | 92.63M | 89.24M | 89.97M | 91.72M | 90.62M | 93.37M | 93.52M | 94.98M | 88.60M | 95.64M | 98.39M | 98.42M | 88.38M | 67.61M | 54.55M |
| Weighted Avg Shares Out (Dil) | 130.45M | 130.06M | 130.60M | 116.54M | 113.74M | 112.73M | 111.77M | 110.73M | 115.00M | 113.00M | 93.82M | 89.81M | 90.67M | 92.95M | 91.52M | 94.29M | 94.64M | 96.23M | 98.58M | 100.29M | 101.13M | 108.38M | 90.25M | 69.19M | 54.55M |
Community Health Systems, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - CYH
NEW YORK, NY / ACCESSWIRE / August 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Community Health Systems, Inc. ("Community Health") (NYSE:CYH) concerning possible violations of federal securities laws. Community Health issued a...
CYH Investors Have Opportunity to Join Community Health Systems, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES, Aug. 2, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Community Health Systems, Inc. ("Community Health" or "the Company") (NYSE: CYH) for violations...
CYH Investors Have Opportunity to Join Community Health Systems, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--CYH Investors Have Opportunity to Join Community Health Systems, Inc. Fraud Investigation with the Schall Law Firm.
CYH ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Community Health Systems, Inc.
NEW YORK, NY / ACCESSWIRE / August 1, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Community Health Systems, Inc. ("Community Health") (NYSE:CYH) concerning possible violations of federal securities laws. Community Health issued a...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Community Health Systems, Inc. - CYH
NEW YORK , Aug. 1, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Community Health Systems, Inc. ("Community Health" or the "Company") (NYSE: CYH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Community Health Systems, Inc. (CYH) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
NEW YORK, NY / ACCESSWIRE / August 1, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Community Health Systems, Inc. ("Community Health") (NYSE:CYH) concerning possible violations of federal securities laws. Community Health issued a...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Community Health Systems, Inc. - CYH
NEW YORK, NY / ACCESSWIRE / July 31, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Community Health Systems, Inc. ("Community Health" or the "Company") (NYSE:CYH). Such investors are advised to contact Danielle Peyton at [email protected]...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Community Health Systems, Inc. - CYH
NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Community Health Systems, Inc. (“Community Health” or the “Company”) (NYSE: CYH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Community Health Systems, Inc. (CYH) Q2 2024 Earnings Call Transcript
Community Health Systems, Inc. (NYSE:CYH ) Q2 2024 Earnings Conference Call July 25, 2024 11:00 AM ET Company Participants Anton Hie - Vice President of Investor Relations Tim Hingtgen - CEO Kevin Hammons - President and CFO Conference Call Participants...
Community Health (CYH) Q2 Earnings Miss on Lower Patient Days
Community Health's (CYH) second-quarter earnings suffer a setback from lower admissions and patient days. Improved occupancy levels partially offset the negatives.
Source: https://incomestatements.info
Category: Stock Reports